Posted in FX-322 News

The end of the road for FX-322

Disappointing news from Frequency Therapeutics.  The company announced that its giving up on FX-322, a drug that it hoped could treat Sensorineural Hearing Loss and…

Continue Reading The end of the road for FX-322